Erudio Healtherudio.com
Drug
Saruparib trials: what clinicians said in public
No HCP commentary report on a trial studying saruparib yet. Erudio has found public clinician commentary on 4 clinical trials studying saruparib: EvoPAR-Breast01, EvoPAR-Prostate01, FONTANA and S2409. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| FONTANA NCT05797168 · AstraZeneca DeepView → | solid tumors | Phase 1/Phase 2 | Deep | View | |||
| S2409 NCT06769126 · SWOG Cancer Research Network StandardView → | extensive stage small cell lung cancer | Phase 2 | Standard | View | |||
| EvoPAR-Prostate01 NCT06120491 · AstraZeneca StandardView → | metastatic castration-sensitive prostate cancer | Phase 3 | Standard | View | |||
| EvoPAR-Breast01 NCT06380751 · AstraZeneca StandardView → | first-line BRCA1/BRCA2/PALB2-mutated HR-positive HER2-negative advanced breast cancer | Phase 3 | Standard | View | |||